文献速递泌尿生殖MR

双参数磁共振成像评估肌层浸润性膀胱癌:系统评价与Meta分析

Biparametric magnetic resonance imaging assessment for detection of muscle-invasive bladder cancer: a systematic review and meta-analysis.
PubMed 文献 · Eur Radiol · 2022-04-01

该系统评价与Meta分析共纳入17项研究2344例患者,比较双参数MRI(T2WI+DWI)与多参数MRI(T2WI+DWI+DCE)对肌层浸润性膀胱癌的诊断效能。双参数MRI与常规VI-RADS诊断效能相似,但双参数MRI在 cutoff 3和4时特异度均高于多参数MRI;以初次经尿道膀胱肿瘤电切术为参考标准的研究敏感度显著高于以二次电切或根治性膀胱切除术为参考标准的研究。

要点

  • 双参数MRI(T2WI+DWI)与多参数MRI诊断肌层浸润性膀胱癌的敏感度无显著差异。
  • 双参数MRI在cutoff 3和4时特异度均显著高于多参数MRI(p=0.02)。
  • 以初次TURBT为参考标准时VI-RADS敏感度被高估,作者建议以二次TURBT为参考标准。

核心结论

  • 双参数MRI与常规VI-RADS对肌层浸润性膀胱癌的诊断效能相似;作者建议以二次经尿道膀胱肿瘤电切术作为参考标准。

研究设计与样本

  • 系统评价与Meta分析,检索Cochrane Library、Embase和PubMed至2021年6月26日,最终纳入17项研究共2344例患者,其中7项研究1041例患者报告了双参数MRI的诊断效能。

诊断标准与关键数值

  • VI-RADS cutoff 3时汇总敏感度0.91(95%CI 0.87-0.94)、特异度0.86(95%CI 0.77-0.91)。
  • VI-RADS cutoff 4时汇总敏感度0.85(95%CI 0.77-0.90)、特异度0.93(95%CI 0.89-0.96)。
  • 双参数MRI cutoff 3时汇总敏感度0.90(95%CI 0.69-0.97)、特异度0.90(95%CI 0.81-0.95)。
  • 双参数MRI cutoff 4时汇总敏感度0.84(95%CI 0.78-0.88)、特异度0.97(95%CI 0.87-0.99)。
  • 双参数MRI与多参数MRI敏感度无显著差异,但双参数MRI在cutoff 3(p=0.02)和cutoff 4(p=0.02)时特异度高于多参数MRI。

临床应用与阅片要点

  • 双参数MRI(T2WI+DWI)可用于临床实践中检测肌层浸润性膀胱癌。
  • 以初次TURBT为参考标准时MRI会高估肌层浸润性膀胱癌诊断,作者建议以二次TURBT作为参考标准。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate if removing DCE from the Vesical Imaging Reporting and Data System (VI-RADS) influences the diagnostic accuracy of muscle-invasive bladder cancer (MIBC). We also explored using different reference standards on the MRI diagnostic performance.

METHODS: We searched the Cochrane Library, Embase, and PubMed databases to June 26, 2021. Pooled biparametric MRI (bpMRI, T2WI+DWI) and multiparametric MRI (mpMRI, T2WI+DWI+DCE) sensitivities and specificities and the diagnostic performances of these methods for MIBC were compared using different reference standards.

RESULTS: Seventeen studies with 2344 patients were finally included, of which 7 studies, including 1041 patients, reported the diagnostic performance of bpMRI. VI-RADS showed sensitivities and specificities of 0.91 (95% CI 0.87-0.94) and 0.86 (95% CI 0.77-0.91) at cutoff scores of 3, and 0.85 (95% CI 0.77-0.90) and 0.93 (95% CI 0.89-0.96) at cutoff scores of 4. BpMRI showed sensitivities and specificities of 0.90 (95% CI 0.69-0.97) and 0.90 (95% CI 0.81-0.95), and 0.84 (95% CI 0.78-0.88) and 0.97 (95% CI 0.87-0.99), respectively, for cutoff scores of 3 and 4. The sensitivities of bpMRI vs mpMRI for MIBC were not significantly different, but bpMRI was more specific than mpMRI at cutoff scores of 3 (p = 0.02) and 4 (p = 0.02). The VI-RADS studies using primary transurethral resection of bladder tumors (TURBT) as the reference standard had significantly higher sensitivities (p < 0.001) than those using secondary TURBT or radical cystectomy as the reference.

DATA CONCLUSION: BpMRI and conventional VI-RADS had similar diagnostic efficacies for MIBC. Since MRI overestimated MIBC diagnoses using primary TURBT as the reference standard, we recommend using secondary TURBT as the reference standard.

KEY POINTS: • Biparametric MRI without DCE had similar diagnostic efficacies for MIBC compared with conventional VI-RADS. • The sensitivity of VI-RADS was overestimated when referring to the primary TURBT results. • Biparametric MRI comprised of T2WI and DWI could be used for detecting MIBC in clinical practice.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Ye, Chen, Xu, et al. Biparametric magnetic resonance imaging assessment for detection of muscle-invasive bladder cancer: a systematic review and meta-analysis. Eur Radiol. 2022. PMID: 35362750. doi:10.1007/s00330-022-08696-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。